Clinical Trials Logo

Clinical Trial Summary

Interventional study with minimal risks and constraints, prospective, monocentric.


Clinical Trial Description

To appreciate the volemia of a patient is a frequent problem in hospital in various situations: renal insufficiency, dyspnea, dysnatremia, etc. The aging of the population, the chronicity of pathologies, overweight among other causes can make it difficult to assess the volume of the disease by the clinic alone. The consequences of a poor evaluation are delayed management and possible iatrogeny. New discrimination markers have emerged to help the clinician such as "brain natriuretic peptide (BNP)" in dyspnea, and especially transthoracic echocardiography (TTE) assessing filling pressures with a high potency. discrimination. In current practice the TTE has unequal accessibility, and requires trained practitioners. It is difficult to have an TTE performed for all patients where the question arises. Just as an assessment of the initial volemia is often necessary, there are few objective monitoring criteria. One can quote the variation of the weight or the evolution of certain biological parameters but none is completely specific. A new marker has been described for a few years: jugular ultrasound. Better accessibility (requires only a probe of 7-9Hz, possibly 5Hz), it can indeed be performed by any practitioner in less than a minute. The jugular distension is a reflection of cardiac pre-load and can be correctly estimated by ultrasound. It has been shown that cardiac decompensated patients have dilated jugular veins compared to a reference population. A low cohort also demonstrated the presence of jugular ultrasound distension in the absence of clinical distension. In a US study, 119 patients admitted to the emergency department for dyspnea had a sensitivity of 99% for a specificity of 59% for trans-jugular ultrasound in cardiogenic edema. However, many applications remain to be explored, and the repeated use of jugular ultrasound in the same patient has never been studied. The accessibility of the measure could make it an excellent monitoring tool. As a clinical situation, the investigators chose a well standardized and studied situation such as blood transfusion that can bridge the preload measured by invasive measures and measured by jugular ultrasound. This situation is complicated in patients in 1 to 5.7% of the situations of secondary pulmonary overload. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03484052
Study type Interventional
Source Rennes University Hospital
Contact
Status Completed
Phase N/A
Start date May 15, 2018
Completion date August 23, 2018

See also
  Status Clinical Trial Phase
Completed NCT02569658 - Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty N/A
Not yet recruiting NCT06095648 - Study Comparing Platelet Transfusion Volumes in Premature Babies N/A
Completed NCT01638416 - Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial Phase 3
Completed NCT01211366 - Use of Cell Salvage Post-operatively in Infants to Decrease Use of Allogeneic Blood Product Transfusions N/A
Recruiting NCT05078086 - Study on the Relationship of Arterial-venous Oxygen Difference and Postoperative Complications After Cardiac Surgery.
Not yet recruiting NCT04859855 - Transfusional Trigger in Post-operative Oncologic Patients in Critical Care N/A
Active, not recruiting NCT05832450 - Predictive Model to Calculate the Risk of RBC Transfusion in Elective Brain Tumours Resections (TScoreBTR)
Completed NCT04282382 - Intraoperative Transfusion Practice in Children
Completed NCT03715348 - Trial of PCC Versus FFP in Patients Undergoing Heart Surgery Phase 2
Completed NCT04456751 - Is Redo Pediatric Cardiac Surgery a Risk Factor for Transfusion?
Recruiting NCT04155489 - The Impact of Perioperative Transfusion on Postoperative Cognitive Dysfunction N/A
Recruiting NCT03005704 - Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets N/A
Completed NCT04304287 - The Benefit of Autologous Blood Transfusion in Total Hip Arthroplasty N/A
Completed NCT04141631 - Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2) N/A
Completed NCT05452538 - AutoTransfusion Versus TRAnsfusion in Cancer Surgery
Completed NCT04245995 - Blood Loss Evaluation Using a Novel Device
Recruiting NCT02132819 - Withholding Feeds During Red Blood Cell Transfusion and TRAGI Phase 4
Completed NCT03260478 - HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial N/A
Completed NCT01012063 - Perioperative Iron With Erythropoietin in Bilateral Total Knee Replacement Arthroplasty (TKRA) N/A
Completed NCT03720184 - Haemo-autologous Antegrade Repriming (HAR) as Minimum Impact Perfusion Strategy for Cardiopulmonary Bypass N/A